Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

<div>Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.</div>

Disease Markers

fig6

Figure 6

Figure 6: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer 

Figure 6 | Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer 